JFGIW
VRTX icon

Johnson Financial Group Inc (Wisconsin)’s Vertex Pharmaceuticals VRTX Stock Holding History

Johnson Financial Group Inc (Wisconsin)’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$66.6K Sell
134
-204
-60% -$90.4K ﹤0.01% 439
2026
Q1 		$151K Sell
338
-29
-8% -$13.5K 0.01% 351
2025
Q4 		$166K Sell
367
-281
-43% -$121K 0.01% 350
2025
Q3 		$254K Buy
648
+224
+53% +$93.6K 0.01% 322
2025
Q2 		$189K Sell
424
-660
-61% -$304K 0.01% 313
2025
Q1 		$526K Sell
1,084
-1,026
-49% -$478K 0.03% 217
2024
Q4 		$974K Sell
2,110
-5,283
-71% -$2.45M 0.05% 151
2024
Q3 		$3.44M Buy
7,393
+487
+7% +$234K 0.16% 80
2024
Q2 		$3.24M Buy
6,906
+5,872
+568% +$2.55M 0.16% 80
2024
Q1 		$432K Buy
1,034
+33
+3% +$13.9K 0.02% 211
2023
Q4 		$407K Buy
1,001
+24
+2% +$8.87K 0.02% 206
2023
Q3 		$340K Sell
977
-90
-8% -$31.5K 0.02% 202
2023
Q2 		$375K Buy
1,067
+318
+42% +$107K 0.03% 210
2023
Q1 		$236K Buy
749
+588
+365% +$176K 0.02% 256
2022
Q4 		$46.5K Hold
161
– – ﹤0.01% 354
2022
Q3 		$49K Buy
161
+36
+29% +$10.4K ﹤0.01% 354
2022
Q2 		$35K Hold
125
– – ﹤0.01% 430
2022
Q1 		$33K Hold
125
– – ﹤0.01% 488
2021
Q4 		$27K Hold
125
– – ﹤0.01% 537
2021
Q3 		$23K Hold
125
– – ﹤0.01% 498
2021
Q2 		$25K Hold
125
– – ﹤0.01% 488
2021
Q1 		$27K Buy
+125
New +$27.5K ﹤0.01% 474
2018
Q1 		– Sell
-28
Closed -$4K – 602
2017
Q4 		$4K Buy
+28
New +$4.15K ﹤0.01% 539

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Johnson Financial Group Inc (Wisconsin)'s VRTX Position: Q2 2026 in Review

Johnson Financial Group Inc (Wisconsin) reduced its Vertex Pharmaceuticals (VRTX) stake by 60% in Q2 2026, selling an estimated $90.4K and leaving 134 shares worth $66.6K. The position accounts for ﹤0.01% of the portfolio, ranked #439.

Johnson Financial Group Inc (Wisconsin) first reported a position in VRTX in Q4 2017 and has held it in 23 quarters since. The position peaked at $3.44M in Q3 2024. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Johnson Financial Group Inc (Wisconsin) held 134 shares of Vertex Pharmaceuticals worth $66.6K as of Q2 2026.
  • Johnson Financial Group Inc (Wisconsin) sold 204 Vertex Pharmaceuticals shares in Q2 2026, an estimated $90.4K.
  • Vertex Pharmaceuticals made up ﹤0.01% of Johnson Financial Group Inc (Wisconsin)'s portfolio in Q2 2026, its #439 holding.
  • Johnson Financial Group Inc (Wisconsin) first reported a position in Vertex Pharmaceuticals in Q4 2017 and has held it in 23 quarters since.
  • Johnson Financial Group Inc (Wisconsin)'s Vertex Pharmaceuticals position peaked at $3.44M in Q3 2024.
  • 1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Johnson Financial Group Inc (Wisconsin)'s 13F filing for Q2 2026, filed 10 Aug 2026.